Protriptyline Hydrochloride

盐酸普罗替林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameProtriptyline Hydrochloride
Drug Alias Nameprotriptilina盐酸丙氨环庚烯盐酸普鲁替林protriptylinum盐酸普洛替林 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine reuptake inhibitor
TargetsMonoamine transporters
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepression
Global Approved IndicationsAttention Deficit Disorder with HyperactivityDepression
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1967/09/27
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeva Women'S Health Llc
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityDepression

Other Information

ATC CodeN06AA11
Related LinksWikipediaDrugBankKEGG